Ernexa Therapeutics Inc. (ERNA) › EPS (Basic)Ernexa Therapeutics Inc. (ERNA) — EPS (Basic)Annual figures by period end, from SEC filings.2020-12-31: $-0.412021-12-31: $-56.612022-12-31: $-8.062023-12-31: $-4.082024-12-31: $-48.962025-12-31: $-2.24$-2.242020-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-2.24—2026-03-13From 2025-01-012024-12-31$-48.96—2026-03-13From 2024-01-012023-12-31$-4.08—2025-03-12From 2023-01-012022-12-31$-8.06—2024-03-14From 2022-01-012021-12-31$-56.61—2023-03-20From 2021-01-012020-12-31$-0.41—2022-07-01From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares